| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |